Skip to main content
. 2022 May 9;9:819311. doi: 10.3389/fmed.2022.819311

Table 1.

Laboratory and clinical characteristics of individuals included in the SCREENING cohort.

Health control
(n = 30)
Diabetic control
(n = 30)
Diabetic kidney disease (DKD)
DKD with heavy proteinuria
(n = 17)
DKD with moderate proteinuria
(n = 12)
Age (years) 50.07 ± 2.35 49.80 ± 3.33 50.18 ± 2.62 52.58 ± 3.65
Sex (male/female) 12/18 18/12 9/8 11/1
History (years) 6.40 ± 1.03 7.77 ± 1.13 7.04 ± 1.62
BMI 22.68 ± 0.73 23.15 ± 0.83 24.23 ± 1.04
SBP (mmHg) 122.90 ± 2.33 144.70 ± 5.53* 137.30 ± 6.10
DBP (mmHg) 77.17 ± 1.59 86.00 ± 2.73 86.25 ± 3.35
FPG (mmol/L) 7.66 ± 0.54 7.49 ± 0.88 6.37 ± 0.53
TC (mmol/L) 3.90 ± 0.16 5.71 ± 0.55* 4.56 ± 0.42
TG (mmol/L) 1.47 ± 0.17 1.85 ± 0.21 1.77 ± 0.29
eGFR (ml/min/1.73 m2) 103.70 ± 3.72 63.66 ± 7.58* 79.50 ± 17.70*
UPCR (g/g) 1.88 ± 0.13 5.72 ± 0.65* 1.81 ± 0.33

BMI, Body Mass Index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; UPCR, urine protein/creatinine ratio.

eGFR was evaluated using the CDK-EPI equation.

The data are shown as the mean ± SEM.

*

P <0.05 vs. the health control or diabetic control.